Lahore: The Board of Directors of Citi Pharma Ltd. is currently convened in Lahore to deliberate on the company's quarterly accounts for the period ending September 30, 2026. This meeting is scheduled to conclude on October 30, 2026, at 16:00.

The outcome of the board's discussions will be disclosed on the next working day, adhering to the designated market category timelines. This announcement is expected to occur before the market opens, specifically between 8:00 AM and 9:30 AM from Monday to Thursday, and before 9:15 AM on Friday. Any adjustments to these timings will be communicated in accordance with notifications from the Exchange under special circumstances.

According to information available from the Pakistan Stock Exchange (PSX), Citi Pharma Ltd. is adhering to regulatory requirements in promptly informing stakeholders about crucial financial decisions. The company's commitment to transparency is evident from the structured timeline for announcements following board meetings.

Further details will be shared once the board meeting concludes and the necessary disclosures are made public. Stakeholders are advised to stay attentive to the forthcoming official communication from Citi Pharma Ltd.